An observational study in Premature Birth, Respiration Failure and Bronchopulmonary Dysplasia, sponsored by Assiut University. Not yet recruiting. Open to participants aged Up to 36 Weeks. Per ClinicalTrials.gov, last updated 2026-09-16.
Sponsored by Assiut University · Observational
Among 12 studies in Premature Birth by Assiut University — 5 open to participants now, 5 under way, none of them phase 3. Premature Birth · Assiut University.
Among the 12 studies in Premature Birth by Assiut University, this one is one of 5 that started in 2026, is one of 7 observational ones, and was the 10th registered.
2,550 studies on the registry are indexed under Premature Birth; 500 are open to participants now.
This study's planned enrollment of 100 is below the median of 120 across 806 observational studies indexed under Premature Birth.
Browse Premature Birth studies →5 of the 12 studies in Premature Birth by Assiut University are open now.
Of the 313 Premature Birth studies recruiting now, 87 (28%) set no upper age limit and 222 (71%) stop at 75 or younger; 239 take children under 18; 105 take healthy volunteers.
This study: Up to 36 Weeks · all sexes · no healthy volunteers.
The full table on the hub →12 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 5 started in 2026.
Median enrollment 94 across the 5 interventional studies, 100 across the 7 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
4 of the studies in Premature Birth by Assiut University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07810543Assiut UniversityFecal Calprotectin in Breastfed vs Formula-Fed Preterm Infants and NEC | 2027-09-10 |
| NCT07821632Assiut UniversityPredictors of Prolonged Mechanical Ventilation in Preterm Infants | 2027-09-25 |
| NCT07818681Assiut UniversityPredictors of Postnatal Growth Failure in Preterm Infants | 2027-09-25 |
| NCT07869719Assiut UniversitynCPAP Versus High-Flow Nasal Cannula in Preterm Infants With RDS | 2027-10-10 |
Among the 12 studies in Premature Birth by Assiut University, from their registry updates:
This prospective cohort study aims to identify the independent predictors of prolonged mechanical ventilation in preterm infants admitted to the Neonatal Intensive Care Unit of Assiut University Children Hospital.
Prolonged mechanical ventilation in preterm infants is associated with increased morbidity including bronchopulmonary dysplasia and neurodevelopmental impairment. This prospective observational study will include preterm infants (born before 37 completed weeks) who require invasive mechanical ventilation.
Infants will be classified into two groups according to the duration of invasive mechanical ventilation: prolonged (>7 days or frequent reintubation) and non-prolonged (≤7 days). clinical, perinatal, and laboratory predictors of prolonged mechanical ventilation will be evaluated.
Preterm infants admitted to the Neonatal Intensive Care Unit of Assiut University Children Hospital who require invasive mechanical ventilation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Preterm infants who require invasive mechanical ventilation for more than 7 days or frequent reintubation
Preterm infants who require invasive mechanical ventilation for ≤7 days.
Occurrence of prolonged mechanical ventilation
Proportion of preterm infants who require invasive mechanical ventilation for more than 7 days or frequent reintubation.
Time frame: Up to 30 days
Duration of invasive mechanical ventilation
Total number of days of invasive mechanical ventilation.
Time frame: Up to 30 days
Successful extubation rate
Proportion of infants who are successfully extubated without re-intubation within 48-72 hours.
Time frame: Up to 30 days
Incidence of bronchopulmonary dysplasia
Proportion of infants diagnosed with bronchopulmonary dysplasia.
Time frame: Up to 30 days
Incidence of neonatal sepsis
Proportion of infants diagnosed with neonatal sepsis.
Time frame: Up to 30 days
Duration of NICU stay
Length of stay in the neonatal intensive care unit in days.
Time frame: Up to 30 days
In-hospital mortality
Proportion of infants who die before hospital discharge.
Time frame: Up to 30 days
No study locations are listed for this record.
Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.
Of 372 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 12 months is below that.
Counting every sponsor, half of 387 studies reached it within 35 months; a quarter within 18 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.